GÜRBÜZ, M. K. Et Al. 2012. Interesting 54 months survival after platinum based induction chemotherapy regimen alone in a patient with T2N0M0 supraglottic carcinoma. ENT UPDATES , vol.2, no.3 , 124-128.

GÜRBÜZ, M. K., ÇAKLI, H., Dincer, M., Ediz, D., DÜNDAR, E., & Ozudogru, E., (2012). Interesting 54 months survival after platinum based induction chemotherapy regimen alone in a patient with T2N0M0 supraglottic carcinoma. ENT UPDATES , vol.2, no.3, 124-128.

GÜRBÜZ, MELEK Et Al. "Interesting 54 months survival after platinum based induction chemotherapy regimen alone in a patient with T2N0M0 supraglottic carcinoma," ENT UPDATES , vol.2, no.3, 124-128, 2012

GÜRBÜZ, MELEK K. Et Al. "Interesting 54 months survival after platinum based induction chemotherapy regimen alone in a patient with T2N0M0 supraglottic carcinoma." ENT UPDATES , vol.2, no.3, pp.124-128, 2012

GÜRBÜZ, M. K. Et Al. (2012) . "Interesting 54 months survival after platinum based induction chemotherapy regimen alone in a patient with T2N0M0 supraglottic carcinoma." ENT UPDATES , vol.2, no.3, pp.124-128.

@article{article, author={MELEK KEZBAN GÜRBÜZ Et Al. }, title={Interesting 54 months survival after platinum based induction chemotherapy regimen alone in a patient with T2N0M0 supraglottic carcinoma}, journal={ENT UPDATES}, year=2012, pages={124-128} }